Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS20080009925 A1
Tipo de publicaciónSolicitud
Número de solicitudUS 11/767,774
Fecha de publicación10 Ene 2008
Fecha de presentación24 Sep 2007
Fecha de prioridad23 Mar 2004
También publicado comoCA2555441A1, CA2555441C, CA2652097A1, CA2652097C, CA2652112A1, CA2652112C, EP1735041A1, EP1735041A4, EP1735041B1, EP1980287A2, EP1980287A3, US7727228, US8382747, US8545491, US8900222, US9808301, US20050215989, US20060122589, US20080039791, US20130172866, US20150045781, WO2005089853A1, WO2005089853B1
Número de publicación11767774, 767774, US 2008/0009925 A1, US 2008/009925 A1, US 20080009925 A1, US 20080009925A1, US 2008009925 A1, US 2008009925A1, US-A1-20080009925, US-A1-2008009925, US2008/0009925A1, US2008/009925A1, US20080009925 A1, US20080009925A1, US2008009925 A1, US2008009925A1
InventoresMarwan Abboud, Rachid Mahrouche, Teresa Mihalik, Chadi Harmouche, Eric Monger
Cesionario originalCryocath Technologies Inc.
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Method and Apparatus for Inflating and Deflating Balloon Catheters
US 20080009925 A1
Resumen
A system and method for controlling the inflation, ablation, and deflation of a balloon catheter. The system includes a balloon catheter, a console, having a pressurized gas or liquid inflation source, and an umbilical system to deliver pressurized coolant to the balloon catheter. The system comprises a PID (Proportional Integral Derivative) controller or other pressure-sensing device that monitors the amount of pressure and volume within the balloon catheter. During inflation, the pressure and/or volume of fluid within the balloon is maintained at a target amount in order to provide sufficient mechanized pressure against the desired target region. The system limits the inflation pressure such that a safe quantity of gas would be released should a leak occur. If the amount falls below a certain threshold level, gas or fluid egress is presumed and the inflation process is halted. In one embodiment, an intermediate console is placed between the console and the balloon catheter and coupled thereto. If a leak is detected, a shut off valve in the intermediate station is activated and the flow of pressurized coolant is interrupted. The balloon catheter can be re-inflated by a separate coolant source in the intermediate station or by a syringe. A further embodiment provides a second balloon to envelope the first balloon and in order to provide a safety vacuum between the two balloons.
Imágenes(13)
Previous page
Next page
Reclamaciones(42)
1-31. (canceled)
32. A method of inflating and deflating a catheter having an expandable membrane, the method comprising the steps of:
controllably inflating the expandable membrane with a fixed amount of coolant.
33. The method of claim 32, further comprising the step of inserting the catheter into a portion of a cardiovascular system.
34. The method of claim 33, further comprising the step of ablating a desired tissue region with the expandable membrane.
35. The method of claim 32, further comprising the step of controllably deflating the expandable membrane.
36. The method of claim 35, wherein the step of controllably deflating the expandable membrane includes terminating inflation of the expandable membrane and evacuating coolant from the expandable membrane when the membrane reaches a predetermined temperature.
37. The method of claim 36, wherein the predetermined temperature is greater than 0° C.
38. The method of claim 32, wherein the step of inflating the expandable membrane includes transferring a predetermined volume of coolant at a predetermined temperature to the expandable membrane.
39. The method of claim 38, wherein the predetermined volume is less than approximately 20 cubic centimeters.
40. The method of claim 32, further comprising keeping the expandable membrane inflated until a region proximate the expandable membrane reaches a predetermined temperature range.
41. The method of claim 32, wherein inflation of the expandable membrane is performed by a pressurized coolant source within a first console coupled to the catheter.
42. The method of claim 41, wherein the pressurized coolant source is a fixed volume reservoir located within the first console.
43. The method of claim 32, further comprising the step of measuring a pressure of coolant within the expandable membrane.
44. The method of claim 43, further comprising the step of evacuating coolant from the expandable membrane in response to the pressure measurement.
45. The method of claim 32, further comprising the step of measuring a volume of coolant within the expandable membrane.
46. The method of claim 45, further comprising the step of evacuating coolant from the expandable membrane in response to the volume measurement.
47. The method of claim 32, further comprising the step of measuring a flow rate of coolant being transferred to the expandable membrane.
48. The method of claim 32, further comprising the step of substantially maintaining the inflation of the expandable membrane by controllably introducing and evacuating coolant from the membrane.
49. The method of claim 48, wherein the step of substantially maintaining the inflation of the expandable membrane is performed by a PID controller.
50. The method of claim 32, wherein the step of ablating the desired tissue region is part of a cryoablation process.
51. The method of claim 32, wherein the step of ablating the desired tissue region is part of a radio frequency ablation process.
52. The method of claim 32, wherein the step of ablating the desired tissue region is part of an ultrasound ablation process.
53. A method for inflating and deflating a catheter having an expandable membrane, the catheter being part of a catheter system including a first console, a catheter, and an umbilical system coupling the first console to the catheter, the method comprising the steps of:
evacuating air from the expandable membrane by creating a vacuum in the expandable membrane;
controllably inflating the expandable membrane proximate a desired tissue region, the expandable membrane being inflated with a fixed amount of coolant in order to provide sufficient mechanical force against the desired tissue region; and
ablating the desired tissue region.
54. The method of claim 53, further comprising the step of inserting the catheter into a portion of a cardiovascular system.
55. The method of claim 53, further comprising the step of controllably deflating the expandable membrane.
56. The method of claim 55, wherein the step of controllably deflating the expandable membrane includes terminating inflation of the expandable membrane and evacuating coolant from the expandable membrane when the membrane reaches a predetermined temperature.
57. The method of claim 56, wherein the predetermined temperature is greater than 0° C.
58. The method of claim 53, wherein the step of inflating the expandable membrane includes transferring a predetermined volume of coolant at a predetermined temperature to the expandable membrane.
59. The method of claim 58, wherein the predetermined volume is less than approximately 20 cubic centimeters.
60. The method of claim 53, further comprising keeping the expandable membrane inflated until a region proximate the expandable membrane reaches a predetermined temperature range.
61. The method of claim 53, wherein inflation of the expandable membrane is performed by a pressurized coolant source within the first console coupled to the catheter.
62. The method of claim 61, wherein the pressurized coolant source is a fixed volume reservoir.
63. The method of claim 53, further comprising the step of measuring a pressure of coolant within the expandable membrane.
64. The method of claim 63, further comprising the step of controllably deflating the expandable membrane by evacuating coolant from the expandable membrane in response to a pressure of the coolant in the expandable membrane.
65. The method of claim 53, further comprising the step of measuring a volume of coolant within the expandable membrane.
66. The method of claim 65, further comprising the step of controllably deflating the expandable membrane by evacuating coolant from the expandable membrane in response to a volume of coolant within the expandable membrane.
67. The method of claim 53, further comprising the step of measuring a flow rate of coolant being transferred to the expandable membrane.
68. The method of claim 53, further comprising the step of substantially maintaining the inflation of the expandable membrane by controllably introducing and evacuating coolant from the membrane.
69. The method of claim 68, wherein the step of substantially maintaining the inflation of the expandable membrane is performed by a PID controller.
70. The method of claim 53, wherein the step of ablating the desired tissue region is part of a cryoablation process.
71. The method of claim 53, wherein the step of ablating the desired tissue region is part of a radio frequency ablation process.
72. The method of claim 53, wherein the step of ablating the desired tissue region is part of an ultrasound ablation process.
Descripción
    CROSS-REFERENCE TO RELATED APPLICATION
  • [0001]
    n/a
  • STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
  • [0002]
    n/a
  • FIELD OF THE INVENTION
  • [0003]
    The present invention relates to a method and system for inflating and deflating balloon catheters and more specifically to a method and system for controlling the inflation and deflation of balloon catheters in order to safely and effectively ablate a tissue region.
  • BACKGROUND OF THE INVENTION
  • [0004]
    The use of fluids with low operating temperatures, or cryogens, has begun to be explored in the medical and surgical field. Of particular interest are the potential use of catheter based devices, which employ the flow of cryogenic working fluids therein, to selectively freeze, or “cold-treat”, targeted tissues within the body. Catheter based devices are desirable for various medical and surgical applications in that they are relatively non-invasive and allow for precise treatment of localized discrete tissues that are otherwise inaccessible. Catheters may be easily inserted and navigated through the blood vessels and arteries, allowing non-invasive access to areas of the body with relatively little trauma.
  • [0005]
    Catheter-based ablation systems are well known in the art. A cryogenic device uses the energy transfer derived from thermodynamic changes occurring in the flow of a cryogen therethrough to create a net transfer of heat flow from the target tissue to the device, typically achieved by cooling a portion of the device to very low temperature through conductive and convective heat transfer between the cryogen and target tissue. The quality and magnitude of heat transfer is regulated by the device configuration and control of the cryogen flow regime within the device.
  • [0006]
    A cryogenic device uses the energy transfer derived from thermodynamic changes occurring in the flow of a refrigerant through the device. This energy transfer is then utilized to create a net transfer of heat flow from the target tissue to the device, typically achieved by cooling a portion of the device to very low temperature through conductive and convective heat transfer between the refrigerant and target tissue. The quality and magnitude of heat transfer is regulated by device configuration and control of the refrigerant flow regime within the device.
  • [0007]
    Structurally, cooling can be achieved through injection of high pressure refrigerant through an orifice. Upon injection from the orifice, the refrigerant undergoes two primary thermodynamic changes: (i) expanding to low pressure and temperature through positive Joule-Thomson throttling, and (ii) undergoing a phase change from liquid to vapor, thereby absorbing heat of vaporization. The resultant flow of low temperature refrigerant through the device acts to absorb heat from the target tissue and thereby cool the tissue to the desired temperature.
  • [0008]
    Once refrigerant is injected through an orifice, it may be expanded inside of a closed expansion chamber, which is positioned proximal to the target tissue. Devices with an expandable membrane, such as a balloon, are employed as expansion chambers. In such a device, refrigerant is supplied through a catheter tube into an expandable balloon coupled to such catheter, wherein the refrigerant acts to both: (i) expand the balloon near the target tissue or the purpose of positioning the balloon, and (ii) cool the target tissue proximal to the balloon to cold-treat adjacent tissue.
  • [0009]
    One of the principal drawbacks to such a technique is that during the inflation phase coolant may seep out of the balloon and get into the bloodstream to cause significant harm. Therefore, if the balloon develops a crack, leak, rupture, or other critical structural integrity failure, coolant may quickly flow out of the catheter. Another situation that may occur during the balloon deflation phase is that the balloon may adhere to the ablated tissue causing severe damage. This may occur after cryoablation or cryomapping. Cryomapping is a procedure that chills conducting target tissue to create a transient electrical effect. By temporarily chilling the target tissue, it allows for precise site confirmation in order to prevent inadvertent ablation. During cryomapping, a procedure known as cryoadhesion takes place. Cryoadhesion is a procedure that ensures the catheter tip remains at the target cite for a seamless transition to cryoablation. In a cryoadhesion procedure, the tip of the catheter firmly attaches to the tissue when it freezes thereby reducing the risk of accidental slippage of the catheter tip. Therefore, during unmonitored balloon deflation, i.e. if the balloon deflates too quickly, the balloon, adhering to the tissue walls, may cause severe damage.
  • [0010]
    Accordingly, it would be desirable to provide an apparatus and method of monitoring and controlling the inflation and deflation phases of a balloon catheter that is adaptable and compatible with all types of balloon ablation catheters, and with all types of ablation procedures, for example RF ablation or cryoablation.
  • SUMMARY OF THE INVENTION
  • [0011]
    The present invention advantageously provides a method and system for controllably inflating and deflating a balloon catheter. The method and system allows for the monitoring of the inflation and deflation phases of a catheter system in order to allow ablation to take place, while detecting unwanted leaks of refrigerant into the bloodstream. Balloon leaks are identified, safety evacuation routes are provided, and a controlled deflation mechanism is presented that prevents damage to the interior blood vessel and tissue region, which may occur during unmonitored deflation due to the adherence of the expandable membrane to the interior of the vessel.
  • [0012]
    In its preferred embodiment, a method of inflating and deflating a catheter during an ablation process, the catheter having an expandable membrane, is provided. The method comprises the steps of controllably inflating the expandable membrane to a target pressure or volume, ablating a desired tissue region while maintaining the target pressure or volume of the expandable membrane, and controllably deflating the expandable membrane so as not to damage desired tissue region.
  • [0013]
    In another aspect of the invention, a method for inflating and deflating a catheter having an expandable membrane during an ablation process is provided. The catheter is part of a catheter system including a console, the catheter, and an umbilical system coupling the console to the catheter. The method comprises the steps of evacuating air from the expandable membrane by creating a vacuum in the expandable membrane, controllably inflating the expandable membrane proximate a desired tissue region, wherein the expandable membrane is inflated to a target pressure or volume in order to provide sufficient mechanical force against the desired tissue region, ablating the desired tissue region while maintaining the expandable membrane at the target pressure or volume, and controllably deflating the expandable membrane such that the desired tissue region is not damaged.
  • [0014]
    In still another aspect of the invention, an apparatus for inflating and deflating a catheter having an expandable membrane is provided. The apparatus comprises a console the console including means for controlling the inflation and deflation of the expandable membrane and for determining if the expandable membrane maintains a target pressure or volume. The console also includes a pressurized inflation source. The apparatus further includes a catheter, and an umbilical system coupling the console to the expandable membrane and delivering pressurized media to the expandable membrane.
  • DESCRIPTION OF THE DRAWINGS
  • [0015]
    A more complete understanding of the present inventions and the attendant advantages and features thereof, will be more readily understood by reference to the following detailed description when considered in conjunction with the accompanying drawings wherein:
  • [0016]
    FIG. 1A illustrates a first embodiment of a double balloon catheter used in conjunction with the present invention;
  • [0017]
    FIG. 1B illustrates a catheter system used in conjunction with the present invention;
  • [0018]
    FIG. 1C illustrates the double balloon catheter of FIG. 1A including a flow sensor located in the handle of the catheter;
  • [0019]
    FIG. 1D illustrates the double balloon catheter of FIG. 1A including a pressure sensor located in the handle of the catheter;
  • [0020]
    FIGS. 2A-2E illustrate a cryoablation system incorporating various embodiments of the apparatus and method of the present invention;
  • [0021]
    FIG. 3 is a schematic representing the mechanical components of the control console of the present invention;
  • [0022]
    FIG. 4 is a schematic representing the mechanical components of the inflation circuit portion of the control console of the present invention;
  • [0023]
    FIG. 5 is a schematic representing the mechanical components of the deflation circuit and main vacuum path of the control console of the present invention; and
  • [0024]
    FIG. 6 is a schematic representing the mechanical components of the safety vacuum path of the control console of the present invention;
  • [0025]
    FIG. 7 is a schematic representation of the embodiment illustrated in FIG. 2A;
  • [0026]
    FIG. 8 is a schematic representation of the embodiment illustrated in FIG. 2B;
  • [0027]
    FIG. 9 is a schematic representation of the embodiment illustrated in FIG. 2C;
  • [0028]
    FIG. 10 is a schematic representation of the embodiment illustrated in FIG. 2D; and
  • [0029]
    FIG. 11 is a schematic representation of the embodiment illustrated in FIG. 2E.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0030]
    The present invention is an apparatus and method for controlling the inflation and deflation of balloon catheters. In its preferred embodiment, the invention requires four steps to properly control the inflation and deflation of the balloon catheter. However, the invention allows for a variety of different implementations in order to accomplish this task. An intermediary control station containing a shut off valve and/or a coolant source may be implemented to assist in properly monitoring, controlling and maintaining the target balloon pressure and/or volume.
  • [0031]
    Referring now to the drawing figures in which like reference designations refer to like elements, a first embodiment of a double balloon catheter used in conjunction with the present invention is shown in FIG. 1A. The catheter 1 includes a handle 2 having a number of proximal connector ports 3 a-3 d. Port 3 a may be a first vacuum connector, having a first vacuum lumen therein, such as a 10 French lumen. Port 3 b may be a coaxial connector having both a vacuum lumen and injection therein, the vacuum lumen being a second vacuum lumen, such as a 8 French lumen. Port 3 c may be an electrical connector. Port 3 d may be a guidewire luer hub.
  • [0032]
    The handle 2 further includes a blood detection board 4 and pressure relief valve 5. The distal end portion of the catheter 1 includes two balloons: an inner balloon 6 a and an outer balloon 6 b surrounding inner balloon 6 a. A soft distal tip 7 is located just distal to the two balloons 6 a and 6 b. When refrigerant is injected into the balloons along lines R as shown, vacuum applied through the ports 3 a and 3 b will serve to draw any fluid within balloons 6 a and 6 b along arrows V out of the balloons and the catheter. Radiopaque marker bands M are located proximate the exit point of the refrigerant injected into balloon 6 a to aid in the positioning and tracking of the device.
  • [0033]
    Catheter 1 includes an elongate shaft having a guidewire 8 and an inner shalt 9 a and outer shaft 9 b. Exemplary embodiments of the inner shaft 9 a include an 8 French shaft, while exemplary embodiments of the outer shaft 9 b include a 10 French shaft.
  • [0034]
    A typical catheter system 10 is shown in FIG. 1B. The system includes a console 20 coupled to one end of an umbilical system 12. The opposing end of umbilical system 12 is coupled to an energy treatment device 22. Energy treatment device 22 may be a medical probe, a catheter, a balloon-catheter, as well as other devices commonly known in the art that are smooth enough to pass easily through blood vessels and heart valves. As shown in FIG. 1A, the energy treatment device 22 includes a balloon structure 23 that can be a single wall or a double wall configuration, wherein the double wall configuration places the space between balloon walls in communication with a vacuum source.
  • [0035]
    Umbilical system 12 is comprised of three separate umbilicals: a coaxial cable umbilical 14, an electrical umbilical 16 and a vacuum umbilical 18. An outer vacuum umbilical is used in the case of a double balloon system; it is not necessary for a single balloon system having only one vacuum lumen. If the user wishes to perform an RF ablation procedure, radiofrequency energy can be provided to electrodes on device 22 via electrical umbilical 16 to perform an RF ablation technique as is common in the art. Electrical umbilical 16 can include an ECG box 82 to facilitate a connection from electrodes on catheter 22 (not shown) to an ECG monitor. Coaxial umbilical 14 includes both a cooling injection umbilical and a vacuum umbilical that provide respective inlet and return paths for a refrigerant or coolant used to cool a tissue-treating end of device 22. The vacuum umbilical 18 is used as safety conduit to allow excess coolant or gas to escape from device 22 if the pressure within the balloon on device 22 exceeds a predefined limit. The vacuum umbilical 18 can also be used to capture air through a leak of the outer vacuum system where it is outside the patient and as a lumen to ingress blood when in the patient.
  • [0036]
    Referring once again to FIG. 1B, catheter system 10 may include one or more sensors #, which are used to monitor the amount of fluid or gas refrigerant injected through the umbilical system and into the balloons. It is contemplated that the sensors may be located in one of several locations throughout catheter system 10. For example, sensor 11 may be located in console 20, ECG Box 82, and/or handle 2.
  • [0037]
    Two different types of sensors are contemplated for use with the present invention in order to monitor how much coolant is flowing into the balloons. A flow sensor 13 shown in FIG. 1C, measures the rate or speed of fluid or gas at a certain location. An exemplary embodiment of flow sensor 13 is the Microbridge Mass Air Flow Sensor by Honeywell®.
  • [0038]
    Alternately, one or more sensors 11 may be a pressure sensor 15 as shown in FIG. 1D. Pressure sensor 15 in FIG. 1D is a differential pressure sensor that can determine the amount of pressure in the balloons by determining the difference in pressure between points p1 and p2 and the velocity through the restriction point d. An exemplary embodiment of pressure sensor 15 is the 26PC SMT Pressure Sensor by Honeywell®.
  • [0039]
    FIGS. 2A-2E illustrate different embodiments of the catheter system 10 of the present invention. In general, the inflation/deflation system described herein can be used with both single and double balloon systems. For a single balloon system, the refrigerant is sprayed into the balloon and creates a circumferential region of cooling through the balloon's perimeter. The refrigerant expands and the vapor is drawn back into the console via the return vacuum lumen. With respect to a double balloon system, a second balloon and second vacuum lumen envelop the single balloon system and are always maintained under vacuum for safety reasons. The vacuum of the outer balloon will capture refrigerant escaping through any breach of the inner balloon system. A flow switch mounted on the outer vacuum system is used to monitor any flow activity. Under normal operation, no fluid should pass through the outer vacuum system. Any discussion of a “flow switch” herein implies a double balloon system. Otherwise, all inflation/deflation methods also apply to a single balloon catheter.
  • [0040]
    Each embodiment includes a console 20 or console 21 an umbilical system comprised of varying combinations of separate umbilicals, and an ablation device 22. Each of the embodiments shown in FIGS. 2A-2E is represented by more detailed corresponding schematic in FIGS. 7-11, respectively, and are discussed in greater detail below.
  • [0041]
    FIG. 2A represents a typical catheter ablation system 10. Console 20 is coupled to a catheter 22 via an umbilical system 12, comprised of coaxial umbilical 14, which transfers coolant from console 20 to catheter 22 and provides a return conduit for the coolant, electrical umbilical 16, which transfers RF energy from console 20 to catheter 22 during an RF ablation procedure or electrical signals during a cryoablation procedure, and safety vacuum umbilical 18, to allow for quick evacuation of coolant if needed.
  • [0042]
    Coolant is provided by a coolant source within console 20. Coolant, typically N2O, passes through the internal piping of console 20 before being transferred to catheter 22 via the coaxial umbilical 14. At the distal end of the umbilical, inside catheter 22, the coolant is released inside the catheter tip cavity, which is under vacuum. Both the phase change from liquid to gas and the sudden expansion of the coolant are endothermic reactions, causing a temperature differential which results in the catheter tip or balloon freezing. The coolant vapor is then returned through the vacuum path via umbilical 14 and into console 20, where it is evacuated through a scavenging line.
  • [0043]
    FIG. 2B represents another catheter ablation system. However, in this embodiment, an intermediary station 74 is inserted into the catheter system. As explained in greater detail below, station 74 contains detection valves to detect a drop in balloon pressure which might indicate a leak, and shut off valves to terminate balloon inflation if necessary. Station 74 is coupled to console 21 and catheter 22 via electrical umbilical 16 and coaxial umbilical 14. Vacuum umbilical 18 provides an emergency evacuation path for coolant from the catheter.
  • [0044]
    FIG. 2C represents the catheter ablation system of FIG. 2A including a secondary coolant source 78 used to re-inflate the expandable membrane, or balloon 23 of catheter 22 via syringe 76.
  • [0045]
    FIG. 2D illustrates two possible configurations for the ablation system. In a first configuration, a secondary coolant source includes a small tank or canister 80 located within an intermediary station 74. In a second configuration, the secondary coolant source includes a small tank or canister 60 located inside the console 21. In both configurations, the secondary coolant source is independent from the source of cooling provided by other components within the console 21 (the primary coolant source), and it does not require the same type of refrigerant that is provided by the primary coolant source.
  • [0046]
    FIG. 2E illustrates a configuration where the secondary cooling source and the primary cooling source are unified and thus share the same source of refrigerant.
  • [0047]
    FIG. 3 refers to a schematic representing the console 20 portrayed in FIGS. 2A and 2C. The schematic shown is designed specially for balloon catheters and contains a series of two and three-way solenoid valves and regulators that assist in monitoring the pressure of the balloon catheter 23, which may drop quickly if a leak of fluid occurs. Device 22 (shown in FIGS. 2A-2E) is a catheter with an expandable membrane 23 at its distal end. Console 20 is represented by the schematic in FIG. 3 that shows the layout of the internal mechanical components of console 20.
  • [0048]
    In an exemplary embodiment, the system is operated in four phases. The first phase is the evacuation flushing phase. When the catheter 22 is inserted inside the patient it is first necessary to evacuate air molecules from within the catheter, air contained inside the umbilical connecting the catheter 22 to the console 20, as well as from the catheter shaft itself. Although it is not theoretically possible to evacuate 100% of the air molecules, by minimizing the amount of air within the umbilical and catheter shaft, the catheter is prepared for inflation and then ablation, while minimizing the dangers associated with fluid egress.
  • [0049]
    During the evacuation/flushing phase, a 3-way solenoid valve 24 is open toward vacuum pump 26, which ensures that there is a vacuum in catheter 22. The 3-way solenoid valve 24 can be replaced by a PID-driven proportional valve. In either configuration, the 2-way solenoid 28 that supports high pressure is closed to prevent any high-pressure gas from reservoir 30 from entering the inner vacuum system/balloon catheter during the refilling process. Reservoir 30 could be a tube or reservoir containing enough fluid volume to fill the umbilical tubes and catheter 22 to a predefined pressure. If the pressure within reservoir 30 exceeds a predetermined pressure setpoint, a check valve 32 will open to evacuate the exceeded amount of coolant such as, for example, nitrous oxide (N2O) in the system in order to keep a fixed amount of nitrous oxide in reservoir 30. During this phase, reservoir 30 is filled with N2O received from N2O source 60. The N2O is received from a high pressure line after leaves tank 60 and passes through a series of regulators, namely, a first regulator 34, a second regulator 36 and then into either a third regulator 38 or a proportional valve, that are adjusted to the predetermined pressure. The reservoir pressure can be controlled through a pressure regulator 38 or through a proportional valve that would refill the tank with different pressure setpoints for different balloon sizes or different inflation pressures. The pressure setpoint can be programmed into a circuit, chip or other memory device that can be located in the handle.
  • [0050]
    Refilling valve 40 opens for a period of time and fills reservoir 30. During this phase, the 2-way solenoid valve 28 remains closed. Also, during this phase, the system is under vacuum and provides verification for any leaks that occur.
  • [0051]
    Thus, when the the catheter is outside the patient, any breach of the inner or outer vacuum systems will be detected by a high baseline flow through the console flow meter. In addition, a flow switch located in the console or in the catheter handle and mounted on the outer vacuum system will also detect a leak of air through a breach of the outer balloon or vacuum lumen. The flow switch is capable of detecting volumes of gas as little as 1 cc of vapor, and flow rates as little as 20 sccm. When the catheter is inserted into the patient, blood ingress through either the inner or outer vacuum lumens or both will be detected by the leak and blood detection systems. In the case of a constant pressure inflation with circulating flow, the balloon pressure can also be controlled with a PID-driven proportional valve located on the return vacuum lumen or a three-way solenoid valve in series with a pressure switch or pressure transducer.
  • [0052]
    Referring to FIG. 4, the inflation phase of the invention will now be discussed. Prior to positioning catheter 22 on the ablation site, the physician must first inflate the expandable membrane 23 inside the heart chamber and then position the balloon 23 proximate the ablation site. During this phase, the system is under vacuum and provides verification for leaks between balloon 23 and the blood. In one embodiment, balloon 23 is inflated by injecting fluid or gas through the umbilical under a fixed flow pressure. This insures a defined and constant pressure inside the balloon in order to provide a mechanical force for inflation. An alternate way to inflate balloon 23 is to use a fixed volume of inflation. This volume would be minimized in order to meet the constraints related to gas egress within the blood stream (maximum of 20 cc within 10 minutes) and meet the requirement for pressure needed to inflate the balloon under the harshest room conditions.
  • [0053]
    FIG. 3 illustrates the inflation portion of the console mechanics of FIG. 2. During the inflation phase, valve 24 is open toward reservoir 30 and valve 28 opens, while refilling valve 40 remains closed. A fixed amount of N2O is injected to inflate balloon 23 in order to provide sufficient mechanical force for inflation. If a leak occurs in the balloon, the released volume of N2O would be no more than 20 cc. The solenoid valve 44 (shown in FIG. 33) remains open during this phase in order to ensure a vacuum in the safety line. If a leak occurs in the inner balloon of the catheter, the flow switch 42 (FIG. 3), detects leaks as small as 1 cc of vapor. Flow switch 42 is active during all phases to prevent any leak of the inner balloon system in catheter 22. The leak and blood detection systems are still active and monitoring any blood ingress through the outer vacuum lumen. After air has been flushed from catheter 22 and the umbilicals connecting catheter 22 to console 20, and balloon 23 has been inflated, ablation may now take place.
  • [0054]
    A transition mode follows inflation but precedes ablation. In the case of cryogenic ablation systems, a transition method is needed to transition from closed pressurized volume to an open circuit, which allows the flow of refrigerant to enter and exit the catheter tip while at the same time controlling the balloon pressure in order to keep the balloon inflated and in place. During the transition, a pressure switch, which is adjusted to a pressure higher than atmospheric pressure but preferably lower than 20 psia, monitors the pressure inside the balloon catheter 22. The solenoid valve 24 remains closed until the pressure in the catheter is higher than the preset switch value after which the solenoid valve opens to allow evacuation of excess refrigerant. When the pressure falls below the reset switch value, the solenoid valve 24 closes to keep the balloon inflated and above atmospheric pressure. During the transition, ablation is already initiated but the pressure switch controls the balloon pressure until refrigerant flow alone maintains the balloon open and above atmospheric pressure. The transition phase is considered complete when certain conditions are met: 1) when the pressure switch commands the solenoid valve 24 to open to vacuum and the balloon pressure remains above the present switch value; 2) the duration of the transition phase exceeds a predetermined time; and 3) the injection pressure reaches a predetermined value that is adequate to generate enough flow to maintain the balloon open. Check valve 56 is used to prevent any abnormal rise in the pressure in the catheter tip. Another check valve 58, shown also in FIG. 6, prevents any excessive pressure in the safety vacuum line and in in the event the soloenoid valve 44 is blocked.
  • [0055]
    During the ablation phase, refrigerant is injected through the umbilical system into the ablation device 22. When injection of refrigerant is desired, N2O gas is released from source 60 and provides high pressure liquid through a check valve 62 and a series of pressure regulators 34 and 36. Regulators 34 and 36 are primary and secondary pressure regulators respectively, which serve to bring the gas pressure down to between 810 and approximately 840 psig. The liquid nitrous oxide goes through a proportional valve 64 driven by a Proportional Integral Derivative (PID) controller 66 so that the refrigerant pressure can be varied from 0 psig to approximately 760 psig, and through an injection solenoid valve 68 which remains open. The N2O then passes through a sub-cooler 70 with various refrigeration components such as a compressor, a condenser, a capillary tube and a heat exchanger, which insures its liquid state through the umbilical and into the small diameter catheter injection tubing. During injection, solenoid vent valve 46 is closed. To detect a failure of this valve, the pressure switch 72 will close when detecting a pressure higher than 15 psig, creating a failure signal.
  • [0056]
    During the injection phase, proportional valve 64 is used to vary the pressure inside the injection line. This in turn will vary the flow rate of refrigerant to the catheter tip. An increase in the flow rate (less restriction by the regulator) lowers the temperature of the catheter tip. Conversely, decreasing the flow rate allows the catheter tip to be warmed by its surroundings.
  • [0057]
    FIG. 5 illustrates the deflation and main path circuitry of the present invention. At the end of the ablation phase, the system provides a method to insure a controlled/slow deflation in order to prevent damaging the ablated tissue during balloon deflation. This can be a hazard due to cryoadhesion, which may occur when the catheter attaches to the tissue during freezing. Referring to both FIGS. 3 and 5, during deflation, the solenoid valve 24 (FIG. 3) remains closed until the temperature in the balloon is higher than a predetermined temperature (usually above freezing to ensure that surrounding tissue has thawed). When the temperature increases to greater than the predetermined temperature, the solenoid valve 24 opens to vacuum and collapses the balloon. On both vacuum paths, liquid sensors and insulated liquid separators 48 and 50 (FIG. 3) are installed to prevent any liquid from entering the vacuum pump 26. If this occurs, injection and/or inflation will be stopped and both valves 52 (FIG. 3) and 44 (FIG. 3) will switch to atmosphere.
  • [0058]
    FIG. 6 illustrates the safety vacuum portion of the console circuitry of FIG. 3. If a leak occurs in the catheter during inflation or ablation, flow switch 42 can detect such a leak in amounts as small as 1 cc of vapor. Upon detection of the leak, inflation of the balloon catheter is stopped. Prior to inflation, the flow switch can detect leaks of the outer balloon or guide wire lumen when the catheter is in the air. In case of pressurization of the safety vacuum line ⅓ psi above atmospheric, a pressure relief valve 58 located distal to the flow switch will vent excess pressure.
  • [0059]
    Referring now to FIG. 7, one embodiment of the present invention is shown. The schematic in FIG. 7 illustrates the mechanical connection of the console 20, umbilical system 12 and catheter 22. The representation in FIG. 7 corresponds to the embodiment shown in FIG. 2A. The internal components of console 20 are similar and correspond to those shown in greater detail in FIG. 3 explained above. In this embodiment, the balloon 23 is inflated by receiving gas or fluid from source 60 via coaxial umbilical 14. PID controller 66 controls the flow of pressurized fluid/gas from console 20 through umbilical system 12 to balloon 23.
  • [0060]
    FIG. 8 shows an alternate embodiment of the invention in which an intermediary station 74 containing all components and circuits to operate the balloon catheter is coupled to console 10, between the console and balloon catheter 23. Station 74 includes a series of shut-off valves and detection switches. Detection circuitry within station 74 can detect if the volume of gas within balloon catheter 23 has exceeded a certain predetermined amount (i.e. 20 cc within the catheter and the umbilical system), and shut-off valves within station 74 are activated, preventing any further inflation. Station 74 advantageously provides a quicker and more effective way of detecting leakage of gas or liquid into the blood stream. If the pressure within balloon catheter 23 drops, this could be an indication that fluid within the balloon has escaped. By inserting station 74 within system 10, a quicker and more efficient way of detecting leaks and preventing unwanted balloon inflation is provided.
  • [0061]
    FIG. 9 shows yet another embodiment of the invention. Here, balloon inflation can be performed by a syringe 76 coupled to a saline water source 78 or any other fluid media including gasses or liquids. This embodiment becomes practical when manual balloon inflation is required.
  • [0062]
    In FIG. 10, intermediary station 74 includes a second inflation source 80. As in the embodiment depicted in FIG. 8, leak detection circuitry and shut-off valves located in station 74 provide an efficient way of detecting leaks and quickly prohibiting the further inflation of balloon catheter 23. Should further inflation be required, a separate pressurized N2O source 80 is provided in station 74, which is at a closer and more convenient location, i.e. nearer the catheter and not in a remote location such as console 20.
  • [0063]
    In FIG. 10, the refilling source 80 is located in the intermediate box 74 and inflation occurs through the outer vacuum umbilical. In FIG. 11, the refilling source is the coolant tank 60 located in the cryoablation console and inflation occurs through the inner vacuum umbilical.
  • [0064]
    It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described herein above. In addition unless mention was made above to the contrary, it should be noted that all of the accompanying drawings are not to scale. A variety of modifications and variations are possible in light of the above teachings without departing from the scope and spirit of the invention, which is limited only by the following claims.
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US3425417 *24 Feb 19654 Feb 1969Kanbar Maurice SRefillable cryogenic probe for surgical use
US3938514 *18 Jul 197417 Feb 1976Boucher Lionel JBladder wash method and apparatus
US4029099 *4 Dic 197514 Jun 1977Loretta Alice FifieldUrine drainage apparatus
US4509370 *30 Sep 19829 Abr 1985Regents Of The University Of CaliforniaPressure-sensitive optrode
US4725267 *6 May 198716 Feb 1988Vaillancourt Vincent LPost-injection needle sheath
US4813425 *26 Ago 198721 Mar 1989American Home Products CorporationFetal electrode product
US4919112 *7 Abr 198924 Abr 1990Schott Fiber OpticsLow-cost semi-disposable endoscope
US5015240 *1 May 199014 May 1991Ian Campbell CreeHypodermic needle shield
US5078713 *30 Nov 19897 Ene 1992Spembly Medical LimitedCryosurgical probe
US5098428 *14 Mar 199124 Mar 1992Sandlin Felix MCryosurgical spraying apparatus
US5205298 *26 Nov 199127 Abr 1993Carroll HurstMethod and apparatus for use in applying elastomeric coverings to body
US5217482 *15 Nov 19918 Jun 1993Scimed Life Systems, Inc.Balloon catheter with distal guide wire lumen
US5314408 *13 Nov 199224 May 1994Cardiovascular Imaging Systems, Inc.Expandable member for a catheter system
US5324286 *21 Ene 199328 Jun 1994Arthur A. Fowle, Inc.Entrained cryogenic droplet transfer method and cryosurgical instrument
US5409469 *4 Nov 199325 Abr 1995Medtronic, Inc.Introducer system having kink resistant splittable sheath
US5423807 *24 Ene 199413 Jun 1995Implemed, Inc.Cryogenic mapping and ablation catheter
US5487385 *3 Dic 199330 Ene 1996Avitall; BoazAtrial mapping and ablation catheter system
US5496311 *2 May 19945 Mar 1996Boston Scientific CorporationPhysiologic low stress angioplasty
US5713951 *5 Jun 19953 Feb 1998Heartport, Inc.Thoracoscopic valve prosthesis delivery device
US5715817 *7 Jun 199510 Feb 1998C.R. Bard, Inc.Bidirectional steering catheter
US5718725 *5 Jun 199517 Feb 1998Heartport, Inc.Devices and methods for intracardiac procedures
US5728151 *5 Jun 199517 Mar 1998Heartport, Inc.Intercostal access devices for less-invasive cardiovascular surgery
US5735290 *28 Jul 19947 Abr 1998Heartport, Inc.Methods and systems for performing thoracoscopic coronary bypass and other procedures
US5755682 *13 Ago 199626 May 1998Heartstent CorporationMethod and apparatus for performing coronary artery bypass surgery
US5766151 *7 Jun 199516 Jun 1998Heartport, Inc.Endovascular system for arresting the heart
US5769702 *1 Feb 199623 Jun 1998Sorenson Critical Care, Inc.Variable positioning gaseous conduit orifice and method of use
US5769812 *16 Oct 199623 Jun 1998Heartport, Inc.System for cardiac procedures
US5855210 *6 Nov 19965 Ene 1999Heartport, Inc.Methods for performing heart surgery
US5860953 *9 Feb 199619 Ene 1999Catheter Imaging Systems, Inc.Steerable catheter having disposable module and sterilizable handle and method of connecting same
US5860970 *31 Mar 199519 Ene 1999Spembly Medical LimitedCryosurgical instrument
US5868702 *17 Mar 19979 Feb 1999Heartport, Inc.System for cardiac procedures
US5868735 *6 Mar 19979 Feb 1999Scimed Life Systems, Inc.Cryoplasty device and method
US5876324 *25 Sep 19972 Mar 1999Trouchine; EugenePenile stimulator device using turbulent water flow and method of use
US5879499 *17 Jun 19969 Mar 1999Heartport, Inc.Method of manufacture of a multi-lumen catheter
US5885238 *30 May 199523 Mar 1999Heartport, Inc.System for cardiac procedures
US5885244 *14 May 199723 Mar 1999Cordis Corporation & University Of MiamiSynchronous, pulsatile angioplasty system
US5902299 *29 Jul 199711 May 1999Jayaraman; SwaminathanCryotherapy method for reducing tissue injury after balloon angioplasty or stent implantation
US5904147 *16 Ago 199618 May 1999University Of MassachusettsIntravascular catheter and method of controlling hemorrhage during minimally invasive surgery
US5906579 *14 Ago 199725 May 1999Smith & Nephew Endoscopy, Inc.Through-wall catheter steering and positioning
US5916212 *23 Ene 199829 Jun 1999Cryomedical Sciences, Inc.Hand held cyrosurgical probe system
US6012457 *8 Jul 199711 Ene 2000The Regents Of The University Of CaliforniaDevice and method for forming a circumferential conduction block in a pulmonary vein
US6024740 *8 Jul 199715 Feb 2000The Regents Of The University Of CaliforniaCircumferential ablation device assembly
US6027476 *19 Sep 199722 Feb 2000Heartport, Inc.Methods and systems for performing thoracoscopic coronary bypass and other procedures
US6033426 *24 Jul 19987 Mar 2000Olympus Optical Co., Ltd.Access device for surgical treatment
US6036697 *9 Jul 199814 Mar 2000Scimed Life Systems, Inc.Balloon catheter with balloon inflation at distal end of balloon
US6043273 *23 Ago 199928 Mar 2000Duke UniversityCompositions, apparatus and methods for facilitating surgical procedures
US6059757 *18 Jun 19969 May 2000CardeonSingle lumen catheter with controlled antegrade and retrograde flow
US6060454 *7 Ago 19989 May 2000Duke UniversityCompositions, apparatus and methods for facilitating surgical procedures
US6168586 *7 Ago 19982 Ene 2001Embol-X, Inc.Inflatable cannula and method of using same
US6179810 *17 Ago 199930 Ene 2001Advanced Cardiovascular Systems, Inc.Catheter with a flexible and pushable shaft
US6179827 *1 Dic 199830 Ene 2001Chase MedicalCatheter having integral expandable/collapsible lumen
US6190348 *20 May 199920 Feb 2001Harris A. TiemannDisposable applicator
US6190353 *11 Oct 199620 Feb 2001Transvascular, Inc.Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US6214002 *13 Mar 200010 Abr 2001Ep Technologies, Inc.Structures and methods for deploying electrode elements
US6221070 *3 Jun 199824 Abr 2001Irvine Biomedical, Inc.Steerable ablation catheter system having disposable shaft
US6223491 *21 Dic 19991 May 2001Ted C. Dial, Jr.Block system
US6224624 *14 Abr 19991 May 2001Innercool Therapies, Inc.Selective organ cooling apparatus and method
US6231518 *26 May 199815 May 2001Comedicus IncorporatedIntrapericardial electrophysiological procedures
US6233491 *22 Sep 199715 May 2001Ep Technologies, Inc.Cardiac mapping and ablation systems
US6235019 *30 Nov 199822 May 2001Cryocath Technologies, Inc.Cryosurgical catheter
US6237604 *7 Sep 199929 May 2001Scimed Life Systems, Inc.Systems and methods for preventing automatic identification of re-used single use devices
US6237605 *21 Sep 199829 May 2001Epicor, Inc.Methods of epicardial ablation
US6238371 *9 Oct 199529 May 2001Pharmacia AbDevice for acclimatization to therapy by injections
US6238428 *9 Feb 199929 May 2001Innercool Therapies, Inc.Selective organ cooling apparatus and method employing turbulence-inducing element with curved terminations
US6241722 *17 Jun 19985 Jun 2001Cryogen, Inc.Cryogenic device, system and method of using same
US6241754 *18 Nov 19965 Jun 2001Ep Technologies, Inc.Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like
US6245064 *11 Ene 200012 Jun 2001Atrionix, Inc.Circumferential ablation device assembly
US6245095 *15 Ene 199912 Jun 2001Innercool Therapies, Inc.Method and apparatus for location and temperature specific drug action such as thrombolysis
US6248089 *7 Sep 199919 Jun 2001Medivice Systems Ltd.Tampon applicator
US6350248 *13 Abr 200026 Feb 2002Heartstent CorporationExpandable myocardial implant
US6355029 *1 Dic 199812 Mar 2002Cryovascular Systems, Inc.Apparatus and method for cryogenic inhibition of hyperplasia
US6361519 *13 Abr 200026 Mar 2002Heartstent CorporationMesh tip myocardial implant
US6383151 *11 Sep 20007 May 2002Chris J. DiederichCircumferential ablation device assembly
US6387092 *7 Sep 199914 May 2002Scimed Life Systems, Inc.Systems and methods to identify and disable re-used single use devices based on time elapsed from first therapeutic use
US6502576 *17 Ago 20007 Ene 2003The Regents Of The University Of CaliforniaDevice and method for forming a circumferential conduction block in a pulmonary vein
US6514245 *19 Jul 20004 Feb 2003Cryovascular Systems, Inc.Safety cryotherapy catheter
US6514249 *2 Mar 20004 Feb 2003Atrionix, Inc.Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US6517533 *4 May 199911 Feb 2003M. J. SwaminathanBalloon catheter for controlling tissue remodeling and/or tissue proliferation
US6517536 *27 Abr 200111 Feb 2003Atricure, Inc.Transmural ablation device and method
US6527768 *18 May 20014 Mar 2003Afx Inc.End-firing microwave ablation instrument with horn reflection device
US6540740 *7 May 20011 Abr 2003Cryocath Technologies Inc.Cryosurgical catheter
US6546935 *22 Dic 200015 Abr 2003Atricure, Inc.Method for transmural ablation
US6551274 *3 Ene 200122 Abr 2003Biosense Webster, Inc.Cryoablation catheter with an expandable cooling chamber
US6569082 *8 Feb 200127 May 2003Origin Medsystems, Inc.Apparatus and methods for cardiac restraint
US6685732 *17 Ago 20013 Feb 2004Innercool Therapies, Inc.Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing microporous balloon
US6689128 *5 Dic 200110 Feb 2004Epicor Medical, Inc.Methods and devices for ablation
US6695769 *25 Sep 200124 Feb 2004The Foundry, Inc.Passive ventricular support devices and methods of using them
US6701931 *5 Dic 20019 Mar 2004Epicor Medical, Inc.Methods and devices for ablation
US6702811 *3 May 20019 Mar 2004Medtronic, Inc.Ablation catheter assembly with radially decreasing helix and method of use
US6719755 *19 Jun 200113 Abr 2004Epicor Medical, Inc.Methods and devices for ablation
US6740104 *31 Jul 200025 May 2004Advanced Cardiovascular Systems, Inc.Enhanced catheter with alignment means
US6989009 *19 Abr 200224 Ene 2006Scimed Life Systems, Inc.Cryo balloon
US20010001830 *5 Ene 200124 May 2001Dobak John D.Method and device for applications of selective organ cooling
US20010001831 *5 Ene 200124 May 2001Dobak John D.Method and device for applications of selective organ cooling
US20010002442 *4 Ene 200131 May 2001Dobak John D.Isolated selective organ cooling method and apparatus
US20020045894 *14 Sep 200118 Abr 2002Cryovascular Systems, Inc.Safety cryotherapy catheter
US20030036752 *14 Sep 200120 Feb 2003Cryovascular Systems, Inc.Cryotherapy methods for treating vessel dissections and side branch occlusion
US20040034344 *16 Ago 200219 Feb 2004Eric RybaTip pressure monitoring for cryoablation catheters
US20050038421 *4 Jun 200317 Feb 2005Cryo Vascular Systems, Inc.Controllable pressure cryogenic balloon treatment system and method
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US8544711 *11 Jun 20121 Oct 2013Covidien LpSurgical stapler with tactile feedback system
US95974806 Oct 201521 Mar 2017Endophys Holding, LLCIntraluminal devices and systems
US963617231 May 20132 May 2017Medtronic Cryocath LpCompliant balloon with liquid injection
US20110092955 *7 Oct 201021 Abr 2011Purdy Phillip DPressure-Sensing Medical Devices, Systems and Methods, and Methods of Forming Medical Devices
US20110092967 *21 Oct 200921 Abr 2011Medtronic Cryocath LpDeflation mechanism for a medical device
US20120255985 *11 Jun 201211 Oct 2012Yong MaSurgical stapler with tactile feedback system
Clasificaciones
Clasificación de EE.UU.607/101, 606/41, 601/2, 607/105
Clasificación internacionalA61F2/958, A61B18/00, A61B18/04, A61B18/14, A61B17/22, A61B18/18, A61B18/02
Clasificación cooperativaA61M25/1018, A61B18/1492, A61B2017/22051, A61B2018/00994, A61M25/10185, A61M25/1011, A61B2018/0212, A61B2018/0262, A61B2018/0022, A61B18/02
Clasificación europeaA61B18/02, A61M25/10E
Eventos legales
FechaCódigoEventoDescripción
20 Ago 2009ASAssignment
Owner name: MEDTRONIC CRYOCATH LP, CANADA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CRYOCATH TECHNOLOGIES INC.;REEL/FRAME:023119/0651
Effective date: 20090814
Owner name: MEDTRONIC CRYOCATH LP,CANADA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CRYOCATH TECHNOLOGIES INC.;REEL/FRAME:023119/0651
Effective date: 20090814